A phagocytosis functional assay measures the ability of phagocytic cells, such as neutrophils, macrophages, monocytes, or microglia/macrophages, to bind and internalize particulate targets including bacteria, yeast particles, beads, or myelin particles. Fluorescent flow-cytometry assays detect target uptake as fluorescence associated with gated phagocytes, while pH-sensitive dyes such as pHrodo increase signal in acidic phagosomal compartments and therefore preferentially report internalized particles rather than particles remaining outside the cell. Microscopy or high-content imaging can be used to confirm intracellular localization and, in some protocols, to follow uptake kinetics.
Cellular Function Validation
Comprehensive assessment of cellular biological behavior under specific physiological or pathological conditions covers aspects such as cell motility, vascular remodeling, and immune-mediated clearance mechanisms. Key assays include angiogenesis experiments—observing capillary-like tube formation by endothelial cells on Matrigel or sprouting from 3D spheroids—and phagocytosis assays, which precisely evaluate endocytic activity by tracking the uptake of fluorescent microspheres or target cells by macrophages or neutrophils. Analyzing cell fate decisions and behavioral characteristics from multiple dimensions provides critical experimental evidence for elucidating the molecular mechanisms of complex diseases and screening for drug targets.
Related Experimental Schemes
Endothelial tube formation assay evaluates the ability of endothelial cells to attach, migrate, align, and organize into capillary-like networks when cultured on gelled basement membrane extract or Matrigel; the readout is the morphology and quantity of tube-like networks, which reflects an in vitro endothelial morphogenesis step related to angiogenesis. Basement membrane extract/Matrigel provides laminin-rich extracellular matrix cues that support endothelial differentiation into capillary-like structures, but it can contain biologically active growth factors, so growth-factor-reduced matrix is preferred when testing defined angiogenic stimulators or inhibitors.
